Literature DB >> 2647640

Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.

R A Maciewicz1, R J Wardale, D J Etherington, C Paraskeva.   

Abstract

Pre-malignant and malignant human colorectal tumour epithelial cell lines both secreted precursor forms of the 2 cysteine proteinases, cathepsins B and L. The amount of proteinases secreted by these cell lines varied according to the cell density. Comparison at similar cell densities showed that the pre-malignant, adenoma-derived cell line (PC/AA) secreted as much, or more, of both cathepsin B and L precursors as did the malignant, carcinoma-derived cell line (PC/JW/FI). However, mature forms of cathepsins B and L were detected in the culture media of only the carcinoma-derived cell line, thus indicating that the invasive potential of a tumour may be related to its ability to process extracellularly the secreted precursor enzyme to a mature and consequently active enzyme, rather than to the amount of proteinase synthesized and/or secreted. Similar results were obtained using 2 other epithelium-derived tumour cell lines, HT/29 (carcinoma) and SP/AN (adenoma). Immunolocation studies showed that cathepsin B was lysosomal while cathepsin L appeared to have a distribution more consistent with a plasma membrane association. Purified human cathepsins B and L (mature form) were capable of solubilizing an isolated basement membrane matrix (bovine anterior lens capsule) in vitro, thus indicating that the secreted mature enzymes and the membrane-associated cathepsin L could potentially degrade basal laminae or sub-endothelial basement membranes in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647640     DOI: 10.1002/ijc.2910430323

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  The application of a novel biotinylated affinity label for the detection of a cathepsin B-like precursor produced by breast-tumour cells in culture.

Authors:  B M Cullen; I M Halliday; G Kay; J Nelson; B Walker
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

2.  Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.

Authors:  Didier Jean; Nathalie Guillaume; Raymond Frade
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

3.  Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.

Authors:  H H Heidtmann; U Salge; M Abrahamson; M Bencina; L Kastelic; N Kopitar-Jerala; V Turk; T T Lah
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

4.  Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism.

Authors:  P Montcourrier; I Silver; R Farnoud; I Bird; H Rochefort
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

5.  Relationship between morphological diversity and AgNORs or cathepsin B expression in colorectal cancers.

Authors:  A Nanashima; Y Tagawa; T Nakagoe; J E Nishizawa-Takano; K Hatano; T Uchikawa; Y Matsumoto; Y Taniguchi; N Fujise; H Ayabe
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

6.  Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L.

Authors:  D Jean; J Hermann; F Rodrigues-Lima; M Barel; M Balbo; R Frade
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

Review 7.  Cathepsin B and other proteases in human colorectal carcinoma.

Authors:  J M Jessup
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

8.  Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.

Authors:  Nathalie Guillaume-Rousselet; Didier Jean; Raymond Frade
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

9.  Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase.

Authors:  J M Delaissé; P Ledent; G Vaes
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

10.  Cathepsin B expression in tumour cells and laminin distribution in pulmonary adenocarcinoma.

Authors:  M Higashiyama; O Doi; K Kodama; H Yokouchi; R Tateishi
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.